← FDA Drug Approvals (Drugs@FDA)

INVIRASE

NDA · New Drug Application · Sponsor: HOFFMANN-LA ROCHE · Approved 2004-12-17

Drug application

FDA Application #

NDA021785

Application type

New Drug Application

Brand name

INVIRASE

Generic name

Saquinavir Mesylate

Active ingredients

SAQUINAVIR MESYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

HOFFMANN-LA ROCHE

First approval

2004-12-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown